Valuation: EBOS Group Limited

Market Cap 3.43B 4.22B 2.39B 2.12B 1.97B 1.79B 3.38B 227B 23.67B 9.28B 118B 8.97B 8.78B 377B P/E 2027 *
14.7x
P/E 2028 * 13x
Enterprise Value 4.45B 5.47B 3.1B 2.75B 2.55B 2.32B 4.38B 294B 30.65B 12.02B 153B 11.62B 11.37B 489B EV / Sales 2027 *
0.32x
EV / Sales 2028 * 0.3x
Free-Float
89.8%
Yield 2027 *
5.72%
Yield 2028 * 6.19%
1 day+0.25%
1 week+7.48%
Current month+4.78%
1 month+0.79%
3 months-9.69%
6 months-8.52%
Current year-26.14%
1 week 19.07
Extreme 19.07
20.58
1 month 18.45
Extreme 18.45
20.58
Current year 18.45
Extreme 18.45
28.09
1 year 18.45
Extreme 18.45
29.5
3 years 18.45
Extreme 18.45
42.55
5 years 18.45
Extreme 18.45
46.75
10 years 16.05
Extreme 16.05
46.75
Manager TitleAgeSince
Chief Executive Officer 51 01/07/2025
Director of Finance/CFO - 30/09/2024
Chief Tech/Sci/R&D Officer - 05/08/2024
Director TitleAgeSince
Chairman 66 -
Director/Board Member - 01/07/2019
Director/Board Member 60 01/07/2021
Date Insider Type Main position Quantity % Market Cap. Importance
9/18/26 A Buy

Director

27 0.0000%
9/18/26 A Buy

Director

160 0.0001%
9/18/26 A Buy

Director

85 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%+7.48%-29.24%-40.19% 2.39B
+0.43%+6.59%+53.41%+103.85% 1,120B
+0.90%-2.25%+33.02%+62.23% 616B
+0.71%+3.24%+25.81%+93.86% 504B
-0.13%+5.98%+32.91%+50.39% 367B
+0.52%+0.24%+73.92%+40.15% 360B
-0.95%+4.70%+19.51%+43.00% 288B
-1.98%+3.73%-0.86%+13.43% 258B
-0.35%+4.25%+46.21%+50.76% 234B
-0.75%+3.32%+32.53%+97.21% 194B
Average -0.13%+3.50%+28.72%+51.47% 394.33B
Weighted average by Cap. +0.13%+3.83%+39.14%+71.37%

Financials

2027 *2028 *
Net sales 14.03B 17.24B 9.76B 8.68B 8.04B 7.32B 13.81B 926B 96.66B 37.9B 483B 36.63B 35.85B 1,541B 14.65B 18.01B 10.19B 9.06B 8.4B 7.64B 14.42B 967B 101B 39.58B 505B 38.26B 37.44B 1,609B
Net income 229M 281M 159M 142M 131M 119M 225M 15.11B 1.58B 618M 7.89B 598M 585M 25.14B 260M 320M 181M 161M 149M 136M 256M 17.2B 1.79B 704M 8.97B 680M 666M 28.61B
Net Debt 1.01B 1.25B 705M 627M 581M 529M 998M 66.95B 6.99B 2.74B 34.94B 2.65B 2.59B 111B 975M 1.2B 678M 603M 559M 509M 960M 64.39B 6.72B 2.63B 33.6B 2.55B 2.49B 107B
Projected Income Statement - Annual - EBOS Group Limited
Logo EBOS Group Limited
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Employees
5,364
Date Price Change Volume
16/10/26 NZ$20.40 +0.25% 140,335
15/10/26 NZ$20.35 +2.88% 187,989
14/10/26 NZ$19.78 +0.30% 91,680
13/10/26 NZ$19.72 -0.90% 119,599
12/10/26 NZ$19.90 +4.85% 121,661
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - EBOS Group Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
16.59AUD
Average target price
23.24AUD
Spread / Average Target
+40.05%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - EBOS Group Limited